This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

April 27, 2023

Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST

Apr 27

Key Sessions

Raffael Nachbagauer

Development of mRNA-Based Seasonal Influenza Vaccines

Moderna, USA

Amita Vaidya

Rational Design and Optimization of mRNA-LNP Vaccines for Influenza

Sanofi, USA

Norbert Pardi

Broadly Protective Influenza Vaccines using Nucleoside-Modified mRNA

University of Pennsylvania, USA

Lawrence Thompson

Challenges and Current Approaches Concerning RNA Analytics for the Successful Development of mRNA Vaccines

Pfizer, USA

Influenza mRNA VaccinesThursday, 27 April 2023 - EST/EDT (Eastern Daylight, GMT-4)

Showing 1 of 1 Streams

Influenza mRNA Vaccines

8:30am - 8:35am

Welcoming Remarks

Lottie Leinfellner - Digital Events Conference Producer, Informa Connect, UK

8:35am - 9:05am

Are Influenza mRNA Vaccines the New Frontier for Tackling Endemic Flu Outbreaks?

Martin Friede - Coordinator, Initiative for Vaccine Research (IVR), World Health Organisation, Switzerland

9:05am - 9:35am

Leveraging mRNA Technology for Pandemic Preparedness: Lessons from COVID-19

Jane True - VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, USA

9:35am - 10:05am

Coffee Break & Networking Opportunities on the ConnectMe Platform

10:05am - 10:35am

Development of mRNA-Based Seasonal Influenza Vaccines

Raffael Nachbagauer - Program Leader & Executive Director, Infectious Disease Development, Moderna, USA

10:35am - 11:05am

Rational Design and Optimization of mRNA-LNP Vaccines for Influenza

Amita Vaidya - Principal Scientist, Delivery and Formulations, Sanofi mRNA Centre of Excellence, Sanofi, USA

11:05am - 11:35am

Broadly Protective Influenza Vaccines using Nucleoside-Modified mRNA

Norbert Pardi - Research Assistant Professor of Medicine, University of Pennsylvania, USA

11:35am - 12:05pm

Unravelling the Impact of RNA Vaccine Induced Inflammation on Adaptive Immunity

John S Tregoning - Reader in Respiratory Infections, Imperial College London, UK

12:05pm - 12:35pm

Coffee Break & Networking Opportunities on the ConnectMe Platform

12:35pm - 1:05pm

Challenges and Current Approaches Concerning RNA Analytics for the Successful Development of mRNA Vaccines

Lawrence Thompson - Associate Research Fellow, Pfizer, USA